COMMUNIQUÉS West-GlobeNewswire

Globus Medical Announces Appointment of Orthopedic Trauma Division’s Vice President of Sales
21/05/2018
AUDUBON, Pa., May 21, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED ), a leading musculoskeletal solutions company, today announced the appointment of Daniel Gregoris to Vice President of Sales for the [...]
Coherus Announces Proposed Public Offering of Common Stock
21/05/2018
REDWOOD CITY, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (Nasdaq: CHRS ), today announced it has commenced an underwritten public offering of $75,000,000 of shares of its common stock. All of the [...]
Syneos Health to Present at Upcoming Investors Conferences
21/05/2018
RALEIGH, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract [...]
Melinta Therapeutics Announces Proposed Offering of Common Stock
21/05/2018
NEW HAVEN, Conn., May 21, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT ), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
MyoKardia Announces Proposed Public Offering of Common Stock
21/05/2018
SOUTH SAN FRANCISCO, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
FibroGen Presents Latest Data From PRAISE Phase 2b Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis at American Thoracic Society 2018
21/05/2018
SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN ), a biopharmaceutical company, today announced that updated results from the company’s randomized, double-blind, placebo-controlled Phase 2b [...]
Sanofi: New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent® (dupilumab) improved moderate-to-severe asthma
21/05/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) New England Journal of Medicine publishes two positive Phase 3 trials showing Dupixent ® (dupilumab) improved moderate-to-severe asthma Results showed Dupixent [...]
Sanofi : Le New England Journal of Medicine publie les résultats positifs de deux essais cliniques de phase III montrant que Dupixent® (dupilumab) améliore l'asthme modéré à sévère
21/05/2018
Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) Le New England Journal of Medicine publie les résultats positifs de deux essais cliniques de phase III montrant que Dupixent ® (dupilumab) améliore l' [...]
UroGen Pharma Announces Positive Interim Results from Pivotal Phase 3 OLYMPUS Trial of UGN-101 (MitoGel™) for Non-Surgical Treatment of Upper Tract Urothelial Cancer (UTUC)
21/05/2018
Interim Results Showed Complete Response (CR) Rate of 59 Percent in Patients with Low-Grade UTUC CRs to Date Remain Durable at Three, Six and Nine-Month Follow-Up RA’ANANA, Israel and NEW YORK, May 21, 2018 (GLOBE [...]
Dova Pharmaceuticals Announces U.S. FDA Approval of DOPTELET® (avatrombopag)
21/05/2018
Company to Host Conference Call at 4:30 pm DURHAM, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced the U.S. Food and Drug Administration (FDA) has completed their [...]
Indiana Biosciences Research Institute names executive director of engagement, communications and external affairs
21/05/2018
INDIANAPOLIS, May 21, 2018 (GLOBE NEWSWIRE) -- The Indiana Biosciences Research Institute (IBRI) today announced the appointment of Mark E. Craft as executive director of engagement, communications and external affairs [...]
Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä
21/05/2018
ORION CORPORATION MANAGERS' TRANSACTIONS 21 MAY 2018 at 19.05 EEST Orion Corporation: Managers' transactions - Karvonen Eero kuolinpesä Orion Corporation has received the following disclosure under Market Abuse [...]
Triangle Business Journal Awards Chiesi USA, Inc. Second Consecutive Corporate Philanthropy Award
21/05/2018
Chiesi in the Community impacts local organizations, communities, patients and employees CARY, N.C., May 21, 2018 (GLOBE NEWSWIRE) -- Chiesi USA (key-ay-zee ) , a specialty pharmaceutical company based in Cary, N.C., [...]
Initial Data from Profound Medical’s TACT Pivotal Clinical Trial Presented at AUA 2018
21/05/2018
TORONTO, May 21, 2018 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX-V: PRN ) (OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that provides the precision of real-time [...]
Milestone Scientific Announces Three Additional Independent Distributors in the U.S. for CompuFlo® Epidural System
21/05/2018
Agreements cover territories within the Pacific Northwest, Southeast and Midwest Reports growing interest following successful showing at The SOAP 50th Annual Meeting LIVINGSTON, N.J., May 21, 2018 (GLOBE NEWSWIRE) -- [...]
Cerner Announces Amendment to Share Repurchase Program
21/05/2018
KANSAS CITY, Mo., May 21, 2018 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN ) today announced that its board of directors approved an amendment to its stock repurchase program on May 17, 2018, at its regularly [...]
Letter to Shareholders from ACOL CEO Curt Fairbrother: May 21, 2018
21/05/2018
CORONA, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- Dear Shareholders: Many of you have been following our company since its inception in 2013 and have seen the steady growth that we have achieved in that time. Our most [...]
NuvusGro (NUVG) Introduces the Nuvus Mobile Mining Unit (MoMu) Utilizing its Grow.Droid Enterprise Technology – MoMu to Mine Bitcoin, Ether, BCH, and Altcoins
21/05/2018
Saint Petersburg, FL, May 21, 2018 (GLOBE NEWSWIRE) -- NuvusGro Corp. (OTC PINK: NUVG), a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and analytical tools for the [...]
Stanford Researchers Presented Results from an Exploratory Study of Serlopitant for the Treatment of Chronic Itch in Epidermolysis Bullosa Patients Indicating Reduction in Itch with Serlopitant Treatment
21/05/2018
Results Presented at the International Investigative Dermatology Meeting REDWOOD CITY, Calif., May 21, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO ), a late-stage biopharmaceutical company focused on [...]

Pages